[Carnitine metabolism in chronic kidney failure]. 1992

F Fiorini, and E Patrone, and A Castellucci
Divisione di Medicina, U.S.L. 2, Sanremese.

Carnitine plays an important role in regulating the flow of energetic substrates and their balance through cellular membranes. Usually in chronic renal failure, increased plasma levels of carnitine are found. In early hemodialysis a slow decrease of the muscle concentrations of carnitine is found, followed by a decrease of plasma concentrations long after substitutive treatment. Several signs and symptoms are attributable to carnitine deficiency. It is reported that these changes regress with suitable supply of intravenous carnitine after dialysis end for 15-30 days, and subsequently with chronic administration in the dialysis fluid.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Fiorini, and E Patrone, and A Castellucci
October 1987, Kidney international. Supplement,
F Fiorini, and E Patrone, and A Castellucci
October 1987, Kidney international. Supplement,
F Fiorini, and E Patrone, and A Castellucci
January 1992, Nihon rinsho. Japanese journal of clinical medicine,
F Fiorini, and E Patrone, and A Castellucci
January 1983, Nephrologie,
F Fiorini, and E Patrone, and A Castellucci
October 2011, Postepy higieny i medycyny doswiadczalnej (Online),
F Fiorini, and E Patrone, and A Castellucci
January 2009, Scandinavian journal of clinical and laboratory investigation,
F Fiorini, and E Patrone, and A Castellucci
January 1977, Medicinski arhiv,
F Fiorini, and E Patrone, and A Castellucci
June 2007, The Journal of nutrition,
F Fiorini, and E Patrone, and A Castellucci
September 1975, Nihon Jinzo Gakkai shi,
F Fiorini, and E Patrone, and A Castellucci
September 1975, Srpski arhiv za celokupno lekarstvo,
Copied contents to your clipboard!